CAY10554 – 25 mg

Brand:
Cayman
CAS:
267654-00-2
Storage:
-20
UN-No:
Non-Hazardous - /

Cyclin-dependent kinases (CDKs) are key regulators of cell cycle progression and are therefore promising therapeutic targets for cancer and neurodegenerative diseases. Cyclin-dependent kinases (CDKs) are key regulators of cell cycle progression and are therefore promising therapeutic targets for cancer and neurodegenerative diseases. CAY10554 is a potent inhibitor of Cdk5 and Cdk2, with IC50 values of 64 and 98 nM, respectively.{15079}  

 

Available on backorder

SKU: 10010301 - 25 mg Category:

Description

A potent inhibitor of Cdk5 and Cdk2, with IC50 values of 64 and 98 nM, respectively


Formal name: N-[5-(1-methylethyl)2-thiazolyl]-benzeneacetamide

Synonyms:  BML-259

Molecular weight: 260.4

CAS: 267654-00-2

Purity: ≥95%

Formulation: A crystalline solid


Product Type|Biochemicals|Kinase Inhibitors|CDKs||Product Type|Biochemicals|Small Molecule Inhibitors|Kinases||Research Area|Cell Biology|Cell Cycle